Search research articles
Contact Us
Filters
Showing results (61-70 of 131) with videos related to
Page
of 14
Sort By:
European Heart Journal
|
November 4, 2005
Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction
Wojciech Wojakowski, Michal Tendera, Anna Zebzda, et al.
Lancet (London, England)
|
September 4, 2016
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study
Emmanuelle Vidal-Petiot, Ian Ford, Nicola Greenlaw, et al.
Clinical Cardiology
|
December 4, 2020
Use of risk scores to identify lower and higher risk subsets among COMPASS-eligible patients with chronic coronary syndromes. Insights from the CLARIFY registry
Arthur Darmon, Gregory Ducrocq, Adam Jasilek, et al.
The American Journal of Cardiology
|
May 20, 2021
Prevalence, Incidence and Prognostic Implications of Left Bundle Branch Block in Patients with Chronic Coronary Syndromes (From the CLARIFY Registry)
Arthur Darmon, Gregory Ducrocq, Yedid Elbez, et al.
Journal of the American College of Cardiology
|
March 19, 2013
Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51)
Jessica L Mega, Eugene Braunwald, Sabina A Murphy, et al.
European Journal of Preventive Cardiology
|
October 25, 2021
Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease
Nadia Bouabdallaoui, Nathan Messas, Nicola Greenlaw, et al.
Journal of the American College of Cardiology
|
August 28, 2007
Resting heart rate in cardiovascular disease
Kim Fox, Jeffrey S Borer, A John Camm, et al.
The American Journal of Medicine
|
January 23, 2017
Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events, and Bleeding in Stable Coronary Artery Disease
Paul R Kalra, Nicola Greenlaw, Roberto Ferrari, et al.
European Heart Journal
|
August 21, 2018
Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry
Emmanuelle Vidal-Petiot, Emmanuel Sorbets, Deepak L Bhatt, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 15, 2016
Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2°P-TIMI 50 trial
Ethan C Kosova, Marc P Bonaca, Mikael Dellborg, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 131) with videos related to
Sort By:
Page
of 14
European Heart Journal
|
November 4, 2005
Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction
Wojciech Wojakowski, Michal Tendera, Anna Zebzda, et al.
Lancet (London, England)
|
September 4, 2016
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study
Emmanuelle Vidal-Petiot, Ian Ford, Nicola Greenlaw, et al.
Clinical Cardiology
|
December 4, 2020
Use of risk scores to identify lower and higher risk subsets among COMPASS-eligible patients with chronic coronary syndromes. Insights from the CLARIFY registry
Arthur Darmon, Gregory Ducrocq, Adam Jasilek, et al.
The American Journal of Cardiology
|
May 20, 2021
Prevalence, Incidence and Prognostic Implications of Left Bundle Branch Block in Patients with Chronic Coronary Syndromes (From the CLARIFY Registry)
Arthur Darmon, Gregory Ducrocq, Yedid Elbez, et al.
Journal of the American College of Cardiology
|
March 19, 2013
Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51)
Jessica L Mega, Eugene Braunwald, Sabina A Murphy, et al.
European Journal of Preventive Cardiology
|
October 25, 2021
Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease
Nadia Bouabdallaoui, Nathan Messas, Nicola Greenlaw, et al.
Journal of the American College of Cardiology
|
August 28, 2007
Resting heart rate in cardiovascular disease
Kim Fox, Jeffrey S Borer, A John Camm, et al.
The American Journal of Medicine
|
January 23, 2017
Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events, and Bleeding in Stable Coronary Artery Disease
Paul R Kalra, Nicola Greenlaw, Roberto Ferrari, et al.
European Heart Journal
|
August 21, 2018
Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry
Emmanuelle Vidal-Petiot, Emmanuel Sorbets, Deepak L Bhatt, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 15, 2016
Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2°P-TIMI 50 trial
Ethan C Kosova, Marc P Bonaca, Mikael Dellborg, et al.
Page
of 14